Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects

Digital therapeutics (DTx) are evidence-based, clinically validated digital technologies that can prevent, diagnose, treat, and manage various diseases and medical conditions. This edited volume provides a comprehensive summary of the current scientific, statistical, clinical, and regulatory aspects of DTx, including its potential to deliver equitable, scalable, personalized, and transformative treatments. It is an invaluable resource for business leaders, researchers, regulatory scientists, and faculty and students involved in digital health and digital medicine.

Format: Hardback
Length: 440 pages
Publication date: 06 December 2022
Publisher: Taylor & Francis Ltd

The advent of digital therapeutics (DTx) in the 21st century has revolutionized medicine, offering evidence-based, clinically validated technologies to prevent, diagnose, treat, and manage a wide range of diseases and medical conditions. With its potential to deliver equitable, massively scalable, personalized, and transformative treatments for unmet medical needs, DTx solutions have garnered significant interest from patients, investors, healthcare providers, health authorities, and other stakeholders.

Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is an extensive compilation of the current scientific, statistical, developmental, and regulatory aspects of DTx. This edited volume aims to provide a comprehensive exposition of digital therapeutics through 19 peer-reviewed chapters authored by esteemed subject matter experts in this rapidly evolving field.

This edited volume serves as a valuable resource for business leaders, researchers, and practitioners in public health, healthcare, digital health, information technology, and biopharmaceutical industries. It will also be of great interest to regulatory scientists involved in the review of DTx products, as well as faculty and students engaged in interdisciplinary research on digital health and digital medicine.

Key Features:

Provides a taxonomy of DTx concepts and serves as a navigational tool for the field.

Explores important strategic aspects of the DTx industry, aiding investors, developers, and regulators in understanding the potential value of DTx.

Expands on existing and emerging state-of-the-art scientific and technological tools, as well as data privacy, ethics, and other relevant considerations.

In conclusion, Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is a comprehensive and authoritative resource that sheds light on the emerging field of DTx. By presenting a comprehensive overview of its scientific, statistical, clinical, and regulatory aspects, this edited volume empowers stakeholders to embrace the transformative potential of digital therapeutics and contribute to the betterment of human health.

Weight: 1011g
Dimension: 254 x 178 (mm)
ISBN-13: 9780367861599